PathPresenter to establish subsidiary in Waterloo Region following Series A round
Canadian-led AI pathology startup believes a physical presence in Canada will drive its push into the local market.
Canadian-led AI pathology startup believes a physical presence in Canada will drive its push into the local market.
Amplitude-created biotech startup with scientific roots in SickKids and U of T aims to advance new disease therapies.
DIGITAL said its investment joins an additional $106 million of industry partner backing.
Portable ultrasound diagnostics startup takes home $95,000 after winning pitch competition in Spain.
Kidney disease treatment company looks to build on work of Chinook Therapeutics, acquired by Novartis last year.
Portfolio includes Active Impact, BKR, Cycle H2O, InvestEco, Raven, Renewal, Sandpiper, Spring, The51.
Teladoc Health’s Dr. Karolina Filipowska on increasing access to care in Canada.
Startup’s devices use fluorescent light to spot elevated bacteria levels in wounds.
Founder and CEO Hamed Shahbazi said spin out will unlock “significant shareholder value.”
The total transaction value is dependent on annual performance over 36 months.
Kitchener-Waterloo startup develops AI-enabled communication with the help of OVHcloud.
Hamilton-based Afynia aims to improve the way endometriosis is diagnosed.
American pharmaceutical giant Eli Lilly and medical device provider Topcon Healthcare join as strategic investors.
Biovectra is being purchased for the second time in five years.
The San Diego-based startup is looking to secure FDA and Health Canada clearance for its blood-testing platform.